Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Double-Blind, Controlled Trial of Oxybutynin in the Management of Hot Flashes

NCT02961790 is registered in ClinicalTrials.gov with Academic and Community Cancer Research United as lead sponsor.

NCT NCT02961790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02961790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Double-Blind, Controlled Trial of Oxybutynin in the Management of Hot Flashes
Lead sponsor
Academic and Community Cancer Research United
Phase
Phase 3
Overall status
Completed
Start date
December 9, 2016
Completion date
April 27, 2018
Enrollment
150 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

breast carcinoma, ductal breast carcinoma in situ, hot flashes, lobular breast carcinoma in situ, no evidence of disease